CURRICULUM VITAE
Name
Tawfeeg A.O.Najjar
Present Academic Rank :
Professor of Clinical Pharmacy
Present Post :
Professor,
Department of Clinical Pharmacy,
College of Pharmacy,
King Saud University,
Riyadh, Saudi Arabia.
Academic qualifications :
1.
1978
B.Sc, Pharmaceutical Sciences,
College of Pharmacy,
King Saud University.
2.
1987
Ph.D.
College of Pharmacy, University of Wales,
Cardiff, U.K.
Thesis Title
"Pharmacokinetics and biochemical studies with medroxyprogestrone acetate
in advanced breast cancer patients".
Supervised by :
Prof. David Luscombe.
Grant by :
Farmitalia Carlo Erba.
Academic titles:
1.
Assistant professor
2.
Associate professor
3.
Professor
1987
1996
2002
Academic experiences
1.
1979-1980
Pharm.D (Student)
University of Minnesota,
U. S. A. (Degree was not obtained).
PROFESSIONAL LICENSURE:
1978
1987
1994
Practicing Pharmacist (K.S.A.)
Assistant Professor of Clinical Pharmacy
Associate Professor of Clinical Pharmacy.
ADMINISTRATIVE POSITIONS
1.
Director for Clinical Pharmacokinetic services
at King Khalid University, Hospital, KSU,
Riyadh, S.A.
1987-1990
Director of Drug and Poison Information Centre,
at College of Pharmacy, KSU, Riyadh, S.A.
1991-1996
Member of the College Council, College of
Pharmacy, KSU, Riyadh, S.A.
1993-1994.
Editor of a newsletter (DPIC) published by
Drug and Poison Information Centre, Department
of Clinical Pharmacy, College of Pharmacy,
KSU, Riyadh, S.A.
1991-1996
Executive member, Cooperate Society for King Saud
University Staff
1996-1998
Chairman, Department of Clinical Pharmacy,
College of Pharmacy, KSU, Riyadh, Saudi Arabia
1998-2002
7.
President of Saudi Pharmaceutical Society
1999-2001
8.
Chairman, preparing committee for clinical pharmacy training program at Saudi
council for health specialities.
2001
9.
Member of the Saudi Pharmacy Board
10.
Member in the private pharmacies committee at the office of commerce
11.
Consultant pharmacies committee at the office of commerce
2.
3.
4.
5.
6.
2002- now
PUBLICATIONS:
A)
Before Ph.D:
1)
B)
Tilmisany and T.A. Najjar. Effect of the venom of the cerastes cerastes
(African desert horned viper) on the response on the rat vas deferens to
field stimulation. Tixicon, 1982, 20(2), 505-50
Promotion to assistant professor
1)
T.A. Najjar, Peritoneal absorption of cefopernzone in rats. Journal of
Chemotherapy 1992, 4 (1): 23-26.
2)
Tawfeeg A.O. Najjar, Abdelrehim M. Morad and Rao Muzaffar Khan. Effect of
indomethacin on the pharmacokinetics of methotrexate in rabbits.
Biopharmaceutic & Drug Disposition, 1992, 13: 321-326.
3)
Tawfeeg A.O. Najjar, Kamal M. Mattar and Ibrahim M. Al-Fawaz. Comparison
of a new high performance liquid chromatography method with fluorescence
polarization immunoassay for analysis of methotrexate. Therapeutic Drug
Monitoring, 1992, 14: 142-146.
4)
Tawfeeg A.O. Najjar and Ibrahim M. Al-Fazan, Pharmacokinetics of
methotrexate in children with acute lymphocytic leukaemia. Chemotherapy
1993, 39: 242-247.
5)
Tawfeeg A.O. Najjar, Mohammed I. Al-Hassan and Rao Muzaffar A. Khan.
Theophylline inhibits the elimination of flumazenil in rabbits. International J.
Pharmaceutic (1993).
6)
J. Al-Wakeel, T. A. Najjar, M.J. Alyamani S. Huraib, A. Al-Haider, H. AbuAisha. Comparison of the effect of three haemodialysis membrane on
vincomycin disposition. International Urology and Nephrology, 1994, 26(2),
223-228.
7)
Al-Hassan M.I., Bawazir S.A., Al-Khamis K.I., Najjar T.A and Al-Ashawi S.A.
Pharmacy manpower and job satisfaction of pharmacist. Proceedings for
planning health care manpower symposium. 6-8 November, 1988, page 145181 (Arabic).
A)
Articles submitted for promotion to professorship :
1.
Najjar T.A., O.A. Al-Sheikh, A.A. Al-Dhawailie, A. Sherfan. Bioequivelence
and Pharmacokinetics of chlorophenemine in healthy human volunteers. Int. J.
Clin. Pharmacol.Therap. 1995, Vol.33(11) 619-622.
2.
A.A. Al-Dhawalie, S.M. Al-Rayes, M.H. Al-Haidary, Najjar T.A., A Nourddin.
A survey of surgical antibiotic prophylaxsis in Al-Sulimania Clinic Riyadh.
Saudi Pharmaceutical Journal, 1995, 3(4) 176-180.
3.
Najjar T.A., Al-Dhawalie A.A. and Tekle A. Comparison of HPLC with FPIA
for analysis of vancomycin in patients with chronic renal failure. J.
Chromatography B: Biomedical Applications 1995; 672:295-299.
4.
Najjar T.A. Effect of cepoperazone on the
pharmacokinetics of methotrexate
in rabbits. Int. J. Pharmaceutics 1995; 131: P. 67-71.
5.
E.A.Hosny, N.M. Ghilzai, T.A. Al-Najjar and M.M. El-Mazar. Hypoglycemic
effect of oral insulin in
diabetic rabbits using PH-Dependent coated
capsules containing sodium salicylate without and with sodium cholate. Drug
Development and
Industrial Pharmacy, 1998; 24(3)307-311.
6.
T.A. Najjar, H.S. Abou-Auda and N.M. Ghilzai. Influence of piperacillin on the
pharmacokinetics of methotrexate and 7-OH hydroxymethetroxate. Cancer
Chemotherapoy Pharmacology; 1998, vol. 42 (5): pp 42342 .
7.
H.S. Abou-Auda, T.A. Najjar, N. Al-Fawzan and N.M. Ghilzai. Ethenic
differences in nifedipine pharmacokinetics, comparison of middle easternern
Arabs with other populations. Saudi Pharm. Journal, 1998, vol 6(No 3-4): 21727.
8.
Nor Eldin A, Al-Khamis K, Bawazir S, Ibrahim O, Al-Najjar T , Al-Hassan M.
Effect of clinical pharmacokinetics consultation service on the use of
Gemtamicin serum levels at a university hospital. Bul. Fac.Pharm.Cairo. Univ.,
1988, vol. 36 No. 1 P. 81-84.
9.
T.A. Najjar, M.Al-ariefi, O.Jabara and M.Dana. Ethical requests received by
drug and poison information centre in Saudi Arabia. Journal Social
Administrative Pharmacy; 2000, Vol. 17 No. 4, P: 234-7.
10.
H.S. Abuauda, T.A.Najjar, K-Al-Khamis, B Al-hadiya, N Ghilzai and N Alfawzan. Liquid chromatographic assay of nifedipine in human plasma and its
application to pharmacokinetic studies. Journal Pharmaceutical Biomedical
Analysis, 2000, vol. 22: 241-249.
11.
Sherif Yahya, Tawfeeg A. Najjar and M –Al-suhaibani. The effect of rebampide
on the cisplatin induced nephrotoxicity in rats. Pharmacological Research,. 2000,
vol 42 (No 1) : pp: 81-86.
12.
T.A.Najjar. The disposition of amiodarone in rats after single and multiple
intraperitoneal doses. European J.Drug Metabolism and Pharmacokinetics :
2000, Vol 25, No ¾: pp. --------------(in press).
13.
T.A.Najjar. A survey on community pharmacies in Riyadh, Saudi Arabia. Saudi
Pharmaceutical Journal , 2001, April , Vol. 9 (No:2), P:
14.
Tawfeeg A. Najjar and Sherif S.Yahya. Effect of cisplatin on the
pharmacokinetics of doxorubicin in rabbits. Chemotherapy., ................
15.
Tawfeeg A.Najjar and Sherif S.Yahya. Cisplatin Pharmacokinetics and its
nephrotoxicity in diabetic rabbits. Chemotherapy, 2001, 47: 128-135.
16.
Tawfeeg A. Najjar. The role of pharmacist in patient counselling. Al-Balga .
1999, vol. 6 (No. 2) 61-76. (Review article)
17.
Shfrif Y.Saad, Tawfeeg A.Najjar and Ammar E Al-Rikabi. The preventive role
of deferoxamine againist acute doxorubibin-induced cardiac renal and hepatic
toxicity in rats. Pharmacological Research., 2000, vol: ..... (No: ....): p: ......... .
18.
Saad S.Y, Najjar T.A, Noreldin A.M and Al-Rikabi A.C. Effect of Gemcitabine
on the cisplatin-induced nephrotoxicity in rats: shedule-dependent study.
Pharmacological Research, 2000, Vol. ..... (No. ), p:
19.
‫محمم د‬
‫مف ددا الا ددد التع د‬، ‫الضددمي أ‬
‫ أ د ال‬،‫ ددس أ دمد د المدادد‬، ‫ أ جد د كال‬،‫العريفدد‬
‫ ال ال ال دمل بماد ة األدتشراب السدئل ف‬،‫األن دز ذي ال دم المتزام ل ركبمفمل كالث مب اتمن ف‬
‫ الم ة العرب ة‬.‫ الع د التدد الع مس‬:‫ ل ع مال الص ل ة‬.
Research published during professorship
1.
Najjar T.A. Study on the distribution of community pharmacies in Riyadh,
in Saudi Arabia. J.Soc.Admins.Pharm., 2003, Vol. 20(2): 72-76.
SUPERVISED RESEARCH ACTIVITIES:
1.
Study the compliance of glucoma patients at KKEH taking pilocarpine eye
drops. (Master students' project).
1.
Study the pharmacist therapeutic intervention at King Fahad National Guards
Hospital in Riyadh (Master student project).
2.
A retrospective assessment of application national cholestrol education program
(NCEP) guidelines at Prince Sultan Cardiac Center (Master student project).
3.
Ethnic differences in nifedipine pharmacokinetics: study in middle eastren Arabs
(Master student project)
The pharmacist role as a prescriber (Mater Student Project)
4.
5.
Drug use evaluation for pharmacokinetics utilized at Riyadh Milatary Hospital
(Master student Project).
Programs evaluation
1)
Involved in the evaluation of several bioequivalence studies conducted at various
countries and submitted to the Gulf Office.
2)
Involved in the evaluation of two diploma programs for Saudi Council for
Health specialities.
3)
Involved in the evaluation of Job Description for pharmacists working in the
Ministry of Health hospitals
4)
Evaluation of research project for King Abdul Aziz University, jeddah.
Grants & Projects
1.
Grant by Research Center at the college of pharmacy , King Saud University
(1989) to study disposition of amiodarone.
2.
Grant provided by British Government: (Summar 1996) "Approach community
pharmacy practice in Great Britain."
3.
4.
5.
Sabbital leave (1996-1997) , KSU, to conduct studies related to community
pharmacies in the Kingdom.
Grant by KACST to study: The role of community pharmacies in the primary
health care in Saudi Arabia. King Abdull Aziz City for Science and Technology
(KACST) Project No: AT-18-67.: Years 2000-2002.
SCIENTIFIC MEETINGS:
1.
T.A. Najjar, J. Al-Wakeel, A. Al-Haider, S. Huraib, M. Al-Yamani and H.
Abu-Aisha. Vancomycin dosing in haemodialysis patients (Abstract in the
proceedings). Symposium organized by Saudi Pharmaceutical Society [Clinical
use of antimicrobial agents]. November 1991, Tabouk, Saudi Arabia.
2.
Najjar T.A., Fish R.G., Keen C.W. and Luscombe D.K. Medroxyprogestrone
acetate in patients with advanced breast cancer. 14th European symposium on
clinical pharmacy, October 14-15, 1985,
Stockholm, Sweden.
3.
Najjar T.A., A.A. Al-Dhawalie. Florescence Polarization Immuno-assay
overestimate vancomycin. Proceedings of 1st International Meeting in Pharmacy
and Pharmaceutical Sciences, 4-7 September 1994, Istanbul, Turkey.
4.
PAPER PRESENTATION: Vancomycin dosing in hemodialysis patients.
Symposium organized by Saudi Pharmaceutical Society. "Clinical use of
Antimicrobial Agents", Tabouk, S.A. Nov. 1991.
5.
CHAIRMAN OF MEETING :
Clinical and Therapeutic update program of fungal infections. Saudi
Pharmaceutical Society, Riyadh, S.A. Sept. 1991.
6.
CHAIRMAN OF MEETING:
"On the danger of narcotics abuse".College of Pharmacy, King Saud University,
Riyadh, S.A. Nov. 1989.
7.
PUBLIC ACTIVITIES:
Organizing one week on the danger of narcotics consisted of (exhibition, posters,
symposium and publication in local newsletter). College of Pharmacy, King
Saud University, Riyadh, S.A. Nov. 1989.
8.
CHAIRMAN OF LECTURE:
"Human blood components : their therapeutic values and their manufacturing
process by Dr. Raouf E. Hakim. College of Pharmacy, King Saud University,
Riyadh, S.A. Mar. 1989.
9.
SYMPOSIUM EXHIBITION:
Organizing the exhibition of the 4th Symposium on Drugs
Pharmacy, King Saud University, Riyadh, S.A. 1988.
,College
of
10.
INTRODUCER
The opening ceremony of the 4th Symposium on Drugs, College of Pharmacy,
King Saud University, Riyadh, S.A. 1988.
11.
DISCUSSION GROUP
Involved in one of the discussion groups organized during the symposium on
health care manpower in Saudi Arabia. Ministry of Health, S.A. Nov. 1988.
12.
Taking part in the discussion organized by Al-Yamamah Magazine. "Problem of
the Week" about toxicity of insecticides. Issue 1208, page 14.
13.
Attending and participating in the discussion of the symposium on "Cooperative
buying group of Gulf States - The current and future". Organized by the office
of GCC countries.
14.
Presented 3 lectures on "Bronchial Asthma: The
pathophysiology
and
Treatment". Part of a Continuing Education program on therapeutic organized by
KSU, 1994.
15.
Presented a talk on a meeting entitled "Cystic fibrosis the clinical manifestation
and treatment approach. Continuing Education Program organized by the Saudi
Pharmaceutical Society, 1995.
16.
Present a talk entitled "Drug use evaluation on health care setting". During the
symposium entitled: Controlling Drug Consumptions in Health Care Settings
held in Riyadh in November 1995.
17.
Lecture - The role of pharmacist in patients counseling. Ist Internationa
Conference on Clinical Pharmacy: Title: "Clinical Pharmacy Future and
Challange". 1-2 april, 1998, Amman, Jordan.
18.
Lecture - Clinical pharmacy practice in the hospitals of Saudi Arabia.
Ist Internationa Conference on Clinical Pharmacy: Title: "Clinical
Pharmacy Future and Challange". 1-2 april, 1998, Amman, Jordan.
19.
Participating and coordinating three Scientific meetings of Riyadh,
Dammam and Jeddah related to community pharmacy management, Oct.
1996.
20.
The community pharmacies in the Kingdom of Saudi Arabia:Future Look.
Presentation to the 5thSaudi pharmaceutical internation conference:
Oct.1999.
Major committees
1)
Chairman: Committee preparing for residency program in pharmacy practice at
the Saudi Council for Health Specialties.
2)
Chairman: Committee preparing Saudi National Formulary (Third edition).
3)
Member of the committee preparing guideline for pharmacists registration at
Saudi Council for Health Specialty.
4)
Chairman: committee organizing for the 6th Saudi International pharmacy
conference held in Riyadh in October, 2001
5)
Member of the committee of the community pharmacies at the Industrial and
commercial office in Riyadh.
6)
Member : The committee of establishing the rules and regulations of pharmacist
registration SCHS (1421)
7)
Consultant: the committee of the community pharmacies at the Industrial and
commercial office in Riyadh.
8)
‫ ل ص لة بدله ئة السعمدية ل تخصصدت‬،‫الم س الع م‬
-1423 ‫الصح ة‬
‫ضم ل اة التس ل كمعددلة الشهددات الما ثقة‬
9)
‫ اله ئة السعمدية ل تخصصدت الصح ة‬،‫ ل ص لة ف‬،‫الم س الع م‬
‫ضم ل اة التع م المستمر الما ثقة‬
10)
1.
Workshops
Teaching skills Organized by Saudi Council for Health Specialities in
coolaboration with College of Physicians & Surgeons of Pakistan. Ocober 22-24,
2002 (16-18/8/1423).
TEACHING AND PROFESSIONAL ACTIVITIES
1.
Participated in teaching courses provided by the Department of Clinical
Pharmacy, College of Pharmacy, King Saud University,
Riyadh,
Saudi
Arabia.
i)
ii)
iii)
iv)
2)
Therapeutics
Interpretation of patients lab. Data Clinical pharmacokinetics
Drug informations
Pharmacy administration.
Supervise pharmacokinetic services at KKUH and rotate with pediatric team
for about one year.